Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Cochlear ( (AU:COH) ) is now available.
Cochlear Limited has announced the issuance of new ordinary fully paid securities to be quoted on the Australian Securities Exchange (ASX). This issuance is part of an employee incentive scheme, reflecting the company’s ongoing commitment to employee engagement and retention. The move is expected to enhance the company’s operational capabilities and strengthen its market position by aligning employee interests with corporate growth objectives.
The most recent analyst rating on (AU:COH) stock is a Sell with a A$272.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company focuses on providing innovative hearing implants to improve the quality of life for individuals with hearing loss.
Average Trading Volume: 176,754
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$20.46B
For an in-depth examination of COH stock, go to TipRanks’ Overview page.